AuditLine › HHS OIG › Centers for Medicare and Medicaid Services
HHS OIG recommendation 21-A-03-124.02
Kaiser Permanente should develop written policies and procedures to validate the amounts its PBM discloses before submitting the DIR reports to CMS.
The recommendation, in the publisher's words
Kaiser Permanente should develop written policies and procedures to validate the amounts its PBM discloses before submitting the DIR reports to CMS.
- Responsible agency
- Centers for Medicare and Medicaid Services
- Issued
- July 13, 2021
- Report
- Audit of Medicare Part D Pharmacy Fees: Group Health Cooperative, Inc. (A-03-19-00002) · find it at HHS OIG
- Kind of report
- Audit
- Agency response
- Concur (as recorded by the publisher)
- Closed
- December 7, 2022 (publisher's date)
- Publisher topics
- Prescription Drug
“Open” and “closed” are the publisher's words. AuditLine repeats them with the date it read them. It does not check whether a recommendation was carried out, and a closed recommendation is not proof that a problem was fixed.
Dated history
- Issued by HHS OIG. (publisher's date)
- Closed, with status “Closed Implemented”. (publisher's date)
- First recorded by AuditLine. (start of AuditLine's own history for this record)
Dates marked "publisher's date" come from the publisher's file. AuditLine's own observations begin November 10, 2026 and are added each time the publisher's file changes.
Other recommendations from this report
1 more, of which 0 are open in the publisher's file.
- Kaiser Permanente validate the point-of-sale fee amounts that its PBM disclosed for CYs 2014 and 2015 and refile the CY 2014 and 2015 DIR reports if appropriate.HHS OIG 21-A-03-124.01 · issued Jul 13, 2021 · closed Dec 7, 2022Closed Implemented
Source
Open this report in HHS OIG's tracker This publisher's records (CSV)
Official export: https://oig.hhs.gov/recommendations/export-recs/. File read , 4,677 rows,
SHA-256 664fdfb3658ecb72…. HHS OIG's status, response, dates and potential-savings labels are the publisher's own claims.